LEO Pharma Announces FDA Acceptance of Dersimelagon NDA with Priority Review and Closes Acquisition from Tanabe Pharma – Business Wire

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Δ